Skip to main content

Table 2 Medication used within the study cohort

From: Disease control in patients with asthma and respiratory symptoms (wheezing, cough) during sleep

Medication

n/N (%)

ICS/LABA

37/55 (67,3)

ICS solo

7/55 (12,7)

LAMA

8/55 (14,5)

SABA

39/55 (70,9)

SAMA

4/55 (7,3)

Omalizumab

3/55 (5,5)

Montelukast

7/55 (12,7)

Mepolizumab/Benralizumab

3/55 (5,5)